Birchview Capital as of June 30, 2020
Portfolio Holdings for Birchview Capital
Birchview Capital holds 51 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 28.2 | $47M | 792k | 58.80 | |
| Accelr8 Technology | 20.1 | $33M | 2.2M | 15.16 | |
| Aspira Womens Health | 7.7 | $13M | 3.3M | 3.84 | |
| Quidel Corporation | 6.9 | $11M | 51k | 223.74 | |
| Neurocrine Biosciences (NBIX) | 5.8 | $9.5M | 78k | 122.00 | |
| ACADIA Pharmaceuticals (ACAD) | 2.7 | $4.5M | 93k | 48.47 | |
| Bluebird Bio | 2.2 | $3.7M | 60k | 61.03 | |
| Karyopharm Therapeutics | 1.9 | $3.2M | 168k | 18.94 | |
| Biogen Idec (BIIB) | 1.8 | $2.9M | 11k | 267.55 | |
| Bmy Cvr Rts 03/31/21 Right | 1.5 | $2.5M | 707k | 3.58 | |
| Oxford Immunotec Global | 1.3 | $2.2M | 170k | 13.00 | |
| United Therapeutics Corporation (UTHR) | 1.3 | $2.2M | 18k | 121.00 | |
| Soleno Therapeutics | 1.1 | $1.8M | 827k | 2.22 | |
| Masimo Corporation (MASI) | 1.1 | $1.8M | 8.0k | 228.00 | |
| Amarin Corp Spons Adr New | 1.1 | $1.8M | 260k | 6.92 | |
| Acceleron Pharma | 1.1 | $1.8M | 19k | 95.28 | |
| Chemocentryx | 1.0 | $1.7M | 30k | 57.53 | |
| Contrafect | 1.0 | $1.6M | 256k | 6.39 | |
| Arena Pharmaceuticals | 0.8 | $1.4M | 22k | 62.95 | |
| Albireo Pharma | 0.8 | $1.3M | 48k | 26.50 | |
| Epizyme | 0.7 | $1.1M | 70k | 16.06 | |
| Equitrans Midstream Corp (ETRN) | 0.7 | $1.1M | 133k | 8.31 | |
| G1 Therapeutics | 0.6 | $970k | 40k | 24.25 | |
| Myokardia | 0.6 | $966k | 10k | 96.60 | |
| Harrow Health (HROW) | 0.6 | $938k | 180k | 5.21 | |
| Vanda Pharmaceuticals (VNDA) | 0.6 | $915k | 80k | 11.44 | |
| ImmunoGen | 0.5 | $874k | 190k | 4.60 | |
| Odonate Therapeutics Ord | 0.5 | $847k | 20k | 42.35 | |
| Corcept Therapeutics Incorporated (CORT) | 0.5 | $841k | 50k | 16.82 | |
| Gilead Sciences (GILD) | 0.5 | $769k | 10k | 76.90 | |
| Biohaven Pharmaceutical Holding | 0.4 | $731k | 10k | 73.10 | |
| Continental Resources | 0.4 | $677k | 39k | 17.54 | |
| Amicus Therapeutics (FOLD) | 0.3 | $573k | 38k | 15.08 | |
| Translate Bio | 0.3 | $538k | 30k | 17.93 | |
| Arvinas Ord (ARVN) | 0.3 | $503k | 15k | 33.53 | |
| Inari Medical Ord | 0.3 | $484k | 10k | 48.40 | |
| Stoke Therapeutics (STOK) | 0.3 | $477k | 20k | 23.85 | |
| Intercept Pharmaceuticals In | 0.2 | $398k | 8.3k | 47.95 | |
| Xencor (XNCR) | 0.2 | $398k | 12k | 32.36 | |
| Progyny (PGNY) | 0.2 | $387k | 15k | 25.80 | |
| Voyager Therapeutics (VYGR) | 0.2 | $379k | 30k | 12.63 | |
| Pioneer Natural Resources | 0.2 | $371k | 3.8k | 97.63 | |
| Kalvista Pharmaceuticals (KALV) | 0.2 | $363k | 30k | 12.10 | |
| Encana Corporation (OVV) | 0.2 | $328k | 34k | 9.55 | |
| Inflarx Nv (IFRX) | 0.2 | $321k | 70k | 4.59 | |
| Tg Therapeutics (TGTX) | 0.2 | $292k | 15k | 19.47 | |
| Workhorse Group Inc ordinary shares | 0.2 | $261k | 15k | 17.40 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $261k | 8.0k | 32.62 | |
| Dicerna Pharmaceuticals | 0.2 | $254k | 10k | 25.40 | |
| Yield10 Bioscience | 0.1 | $118k | 19k | 6.23 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $95k | 20k | 4.75 |
